pyrroles has been researched along with Venous Thrombosis in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 15 (71.43) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Li, X; Ling, G; Liu, C; Wang, Y; Zhang, P; Zhao, Z | 1 |
| Danese, S; Fan, H; Jones, TV; Koram, N; Lawendy, N; Modesto, I; Panés, J; Quirk, D; Reinisch, W; Sandborn, WJ; Sands, BE; Su, C | 1 |
| Desai, RJ; Kim, SC; Pawar, A; Weinblatt, ME | 1 |
| Ali, Z; Chebil, S; Hunor, S; Korri-Youssoufi, H; Kuphal, M; Lakey, A; Marti, JS; Ohlander, A; Scott, SM | 1 |
| Ahn, H; Hong, JH; Jeong, IG; Kim, CS; Kwon, T; Lee, JL; Song, C; You, D | 1 |
| Aigner, F; Heidegger, I; Horninger, W; Pichler, R; Tulchiner, G | 1 |
| Fan, X; Gong, P; Guo, Z; Li, Y; Liu, Y; Nie, M; Sun, X; Wang, Y; Yang, D; Zhang, F | 1 |
| Amraoui, S; Boulon, C; Conri, C; Constans, J; Solanilla, A; Viguier, JB | 1 |
| Escudier, B; Gore, M; Mickisch, G; Nuijten, M; Procopio, G; Walzer, S | 1 |
| Bex, A; Blank, C; Boven, E; Haanen, JB; Meijerink, MR; Van der Veldt, AA | 1 |
| Gajda, M; Kroeger, N; Petersen, I; Settmacher, U; Steiner, T; Wunderlich, H; Zanow, J | 1 |
| Ali, Z; Chebil, S; Errachid, A; Hafaiedh, I; Jaffrezic-Renault, N; Korri-Youssoufi, H; Sauriat-Dorizon, H | 1 |
| Barbaud, A; Cuny, JF; Granel-Brocard, F; Guyot-Caquelin, P; Marchal, A; Schmutz, JL; Spaeth, D; Trechot, P | 1 |
| Abel, EJ; Brugarolas, J; Chapin, BF; Cost, NG; Culp, S; Delacroix, SE; Karam, JA; Margulis, V; Raj, GV; Sagalowsky, AI; Sleeper, JP; Smith, PJ; Wood, CG; Youssef, RF | 1 |
| Bex, A; Clarke, N | 1 |
| Karska-Basta, I; Kubicka-Trząska, A; Romanowska-Dixon, B; Undas, A | 1 |
| Fingerle, A; Gschwend, JE; Hauner, K; Horn, T; Kübler, HR; Maurer, T; Retz, M; Schulz, S; Thalgott, MK | 1 |
| Böhm, M; Dirnagl, U; Endres, M; Gertz, K; Laufs, U; Lindauer, U; Nickenig, G | 1 |
| Andrus, MR | 1 |
| Beeram, M; Berg, K; de Bono, JS; Eckhart, SG; Forero, L; Hammond, LA; Izbicka, E; Mita, AC; Mita, MM; Patnaik, A; Rowinsky, EK; Simmons, P; Takimoto, C; Tolcher, AW; Weiss, GR | 1 |
| Beckmann, S; Bocksch, W; Gross, M; Hausmann, D; Karsch, KR; Koschyk, DH; Kreuzer, J; Schartl, M; Voelker, W | 1 |
1 review(s) available for pyrroles and Venous Thrombosis
| Article | Year |
|---|---|
Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature.
Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atorvastatin; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Indoles; International Normalized Ratio; Male; Patient Compliance; Pyrroles; Simvastatin; Venous Thrombosis; Warfarin | 2004 |
2 trial(s) available for pyrroles and Venous Thrombosis
| Article | Year |
|---|---|
A phase II, pharmacokinetic, and biologic study of semaxanib and thalidomide in patients with metastatic melanoma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Area Under Curve; Asthenia; Dose-Response Relationship, Drug; Edema; Female; Half-Life; Headache; Humans; Indoles; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Peripheral Nervous System Diseases; Protein Kinase Inhibitors; Pyrroles; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Venous Thrombosis | 2007 |
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.
Topics: Anticholesteremic Agents; Arteriosclerosis; Arthralgia; Atorvastatin; Butyrates; Cholesterol; Cholesterol, HDL; Cholestyramine Resin; Coronary Disease; Creatinine; Exanthema; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Patient Dropouts; Pyrroles; Treatment Outcome; Triglycerides; Ultrasonography, Interventional; Venous Thrombosis | 2001 |
18 other study(ies) available for pyrroles and Venous Thrombosis
| Article | Year |
|---|---|
Biomimetic platelet-camouflaged drug-loaded polypyrrole for the precise targeted antithrombotic therapy.
Topics: Biomimetics; Fibrinolytic Agents; Humans; Nanoparticles; Pharmaceutical Preparations; Polymers; Pyrroles; Quality of Life; Thrombosis; Venous Thrombosis | 2023 |
Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme.
Topics: Adult; Aged; Cohort Studies; Colitis, Ulcerative; Female; Humans; Incidence; Male; Middle Aged; Piperidines; Pulmonary Embolism; Pyrimidines; Pyrroles; Retrospective Studies; Risk Factors; Venous Thromboembolism; Venous Thrombosis; Young Adult | 2019 |
Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study.
Topics: Adult; Aged; Arthritis, Rheumatoid; Cohort Studies; Databases, Factual; Female; Humans; Incidence; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Proportional Hazards Models; Pulmonary Embolism; Pyrimidines; Pyrroles; Tumor Necrosis Factor Inhibitors; Venous Thromboembolism; Venous Thrombosis | 2019 |
Impedimetric array in polymer microfluidic cartridge for low cost point-of-care diagnostics.
Topics: Antibodies, Immobilized; Biomarkers; Biosensing Techniques; Electric Impedance; Electrodes; Equipment Design; Fibrin Fibrinogen Degradation Products; Humans; Lab-On-A-Chip Devices; Limit of Detection; Point-of-Care Systems; Polyethylenes; Polymerization; Polymers; Pulmonary Embolism; Pyrroles; Venous Thrombosis | 2019 |
Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplastic Cells, Circulating; Nephrectomy; Niacinamide; Phenylurea Compounds; Prognosis; Proportional Hazards Models; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Retrospective Studies; Sorafenib; Sulfonamides; Sunitinib; Survival Analysis; Thrombectomy; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2014 |
Paratesticular Metastasis of a Clear-Cell Renal-Cell Carcinoma With Renal Vein Thrombus Mimicking Primary Testicular Cancer.
Topics: Carcinoma, Renal Cell; Diagnosis, Differential; Humans; Indoles; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Nephrectomy; Orchiectomy; Pyrroles; Sunitinib; Testicular Neoplasms; Thrombectomy; Treatment Outcome; Venous Thrombosis | 2017 |
Design, synthesis, and structure-activity relationship of novel and effective apixaban derivatives as FXa inhibitors containing 1,2,4-triazole/pyrrole derivatives as P2 binding element.
Topics: Animals; Binding Sites; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Design; Factor Xa; Factor Xa Inhibitors; Humans; Models, Molecular; Molecular Structure; Pyrazoles; Pyridones; Pyrroles; Rabbits; Rats; Structure-Activity Relationship; Triazoles; Venous Thrombosis | 2016 |
[An image of vena cava thrombosis].
Topics: Adenocarcinoma, Clear Cell; Aged, 80 and over; Angiogenesis Inhibitors; Fibrinolytic Agents; Heart Atria; Heparin, Low-Molecular-Weight; Humans; Image Processing, Computer-Assisted; Indoles; Kidney Neoplasms; Liver Neoplasms; Male; Nephrectomy; Postoperative Complications; Pyrroles; Recurrence; Sunitinib; Thrombectomy; Tinzaparin; Tomography, X-Ray Computed; Vena Cava, Inferior; Venous Thrombosis | 2009 |
Costs of managing adverse events in the treatment of first-line metastatic renal cell carcinoma: bevacizumab in combination with interferon-alpha2a compared with sunitinib.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Renal Cell; Clinical Trials, Phase III as Topic; Drug-Related Side Effects and Adverse Reactions; France; Gastrointestinal Diseases; Germany; Health Care Costs; Hematologic Diseases; Hospital Costs; Hospitalization; Humans; Hypertension; Indoles; Interferon alpha-2; Interferon-alpha; Italy; Kidney Neoplasms; Protein Kinase Inhibitors; Pyrroles; Recombinant Proteins; Sunitinib; United Kingdom; Venous Thrombosis | 2010 |
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
Topics: Adult; Angiogenesis Inhibitors; Bone Neoplasms; Carcinoma, Renal Cell; Disease Progression; Fatal Outcome; Humans; Indoles; Kidney Neoplasms; Liver Neoplasms; Middle Aged; Neoadjuvant Therapy; Nephrectomy; Pyrroles; Sunitinib; Time Factors; Tomography, X-Ray Computed; Vena Cava, Inferior; Venous Thrombosis | 2010 |
Downsizing a tumor thrombus of advanced renal cell carcinoma with neoadjuvant systemic therapy and resulting histopathological effects.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Humans; Indoles; Kidney Neoplasms; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplastic Cells, Circulating; Nephrectomy; Pyrroles; Sunitinib; Thrombectomy; Tomography, X-Ray Computed; Treatment Outcome; Vena Cava, Inferior; Venous Thrombosis | 2010 |
Electrochemical detection of D-dimer as deep vein thrombosis marker using single-chain D-dimer antibody immobilized on functionalized polypyrrole.
Topics: Biomarkers; Biosensing Techniques; Conductometry; Equipment Design; Equipment Failure Analysis; Fibrin Fibrinogen Degradation Products; Humans; Polymers; Pyrroles; Single-Chain Antibodies; Venous Thrombosis | 2010 |
[Leg ulcerations and sunitinib].
Topics: Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Eruptions; Female; Humans; Indoles; Kidney Neoplasms; Leg Ulcer; Liver Neoplasms; Lung Neoplasms; Pyrroles; Risk Factors; Sarcoma; Sunitinib; Venous Thrombosis | 2010 |
The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Chi-Square Distribution; Drug Administration Schedule; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Nephrectomy; Patient Selection; Proportional Hazards Models; Protein Kinase Inhibitors; Pyrroles; Radiography; Retrospective Studies; Risk Assessment; Risk Factors; Sunitinib; Texas; Thrombectomy; Time Factors; Treatment Outcome; Tumor Burden; Vena Cava, Inferior; Venous Thrombosis | 2011 |
Targeted caval cytoreduction: solid foundations or shifting sands?
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Evidence-Based Medicine; Humans; Indoles; Kidney Neoplasms; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Invasiveness; Nephrectomy; Patient Selection; Protein Kinase Inhibitors; Pyrroles; Risk Assessment; Risk Factors; Sunitinib; Thrombectomy; Time Factors; Treatment Outcome; Tumor Burden; Vena Cava, Inferior; Venous Thrombosis | 2011 |
Altered fibrin clot properties in patients with retinal vein occlusion.
Topics: C-Reactive Protein; Coronary Artery Disease; Female; Fenofibrate; Fibrin; Fibrinolysis; Heptanoic Acids; Homocysteine; Humans; Hypersensitivity, Immediate; Laser Coagulation; Lipoprotein(a); Male; Pyrroles; Retinal Vein; Retinal Vein Occlusion; Simvastatin; Tetrahydroisoquinolines; Thrombosis; Venous Thromboembolism; Venous Thrombosis | 2011 |
Presurgical treatment with sunitinib for renal cell carcinoma with a level III/IV vena cava tumour thrombus.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Humans; Indoles; Kidney Neoplasms; Neoplastic Cells, Circulating; Pyrroles; Sunitinib; Vena Cava, Inferior; Venous Thrombosis | 2012 |
Withdrawal of statin treatment abrogates stroke protection in mice.
Topics: Animals; Aorta; Atorvastatin; Bleeding Time; Blood Coagulation; Brain; Brain Ischemia; Disease Models, Animal; Drug Administration Schedule; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ligation; Mice; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Platelet Activation; Pyrroles; rhoA GTP-Binding Protein; RNA, Messenger; Stroke; Substance Withdrawal Syndrome; Vena Cava, Inferior; Venous Thrombosis | 2003 |